D. Teachey

Oncology · 2009–2016

A researcher in the Science corpus: 8 papers; trusts 3 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom D. Teachey trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Porter
  2. S. Maude
  3. B. Levine

Who trusts D. Teachey overall

  1. Jennifer N. Brudno

Papers from D. Teachey's perspective

Ordered by how strongly the researchers D. Teachey trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia (New England Journal of Medicine)
  2. Familial and acquired hemophagocytic lymphohistiocytosis (European Journal of Pediatrics)
  3. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia (Science Translational Medicine)
  4. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia (Science Translational Medicine)
  5. A Simple Sequentially Rejective Multiple Test Procedure
  6. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis (Pediatric Blood & Cancer)
  7. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia (Science Translational Medicine)
  8. IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6 (International Journal on Biological Sciences)
  9. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with… (Blood)
  10. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. (Blood)

Their papers